The 20 Best HER-2 Positive Breast Cancer Doctors Near Me in Ypsilanti, MI

Dr. Morikawa joined the faculty in August 2014. After earning her M.Mus. in Piano Performance and M.PH in Epidemiology and Biostatistics from Boston University, Dr. Morikawa received her MD/Ph.D. at the Emory University School of Medicine. After completing her internal medicine residency training at Emory, she underwent fellowship training in Medical Oncology at Memorial Sloan Kettering Cancer Center. In 2014, she joined the faculty of the University of Michigan. She specializes in the care of patients with breast cancer at the Rogel Cancer Center. Her research involves clinical and translational investigations in breast cancer as well as brain and leptomeningeal metastases from solid tumors. Dr. Morikawa is rated as a Distinguished provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Morikawa is board certified in Internal Medicine and Medical Oncology.

Dr. Jeruss is a Professor of Surgery and the Director of the University of Michigan Breast Care Center. She also holds appointments in the Departments of Pathology and Biomedical Engineering at the University of Michigan. Dr. Jeruss received her undergraduate degree in neuroscience and history from Brandeis University and her medical degree from the University of Vermont. Dr. Jeruss completed her General Surgery residency training at Northwestern University Medical School and holds a PhD from Northwestern, having done her dissertation in the field of breast cancer biology. She completed her fellowship in Breast Surgical Oncology at M.D. Anderson Cancer Center in 2006, and returned to Northwestern as Associate Professor of Surgery in the Division of Breast Surgery before joining the University of Michigan faculty.Dr. Jeruss is board certified in General Surgery and is a member of several professional societies. Through her basic and clinical research program, Dr. Jeruss has been actively involved in the training of high school students, undergraduates, graduate students at the PhD and post-doctoral levels, medical students, and residents. She has published numerous manuscripts and book chapters, and has also received many awards for teaching and research. Dr. Jeruss is rated as a Distinguished provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, Mastectomy, and Lymphadenectomy. Dr. Jeruss is board certified in Surgery.

Marie-adele Kress is a Radiation Oncologist practicing medicine in Ypsilanti, Michigan. She has been practicing medicine for over 17 years. Dr. Kress is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Laryngeal Cancer, Prostate Cancer, and Pleuropulmonary Blastoma.

Walter Sahijdak is a Radiation Oncologist practicing medicine in Ypsilanti, Michigan. Dr. Sahijdak is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Breast Cancer.

Joel Wilkie is a Radiation Oncologist practicing medicine in Ypsilanti, Michigan. Dr. Wilkie is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses HER-2 Positive Breast Cancer, Lung Cancer, Prostate Cancer, and Familial Prostate Cancer.

Richard Cattaneo is a Radiation Oncologist practicing medicine in Ypsilanti, Michigan. Dr. Cattaneo is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET).

Eva Bieniek is a Radiation Oncologist practicing medicine in Ypsilanti, Michigan. Dr. Bieniek is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Lung Cancer, Pleuropulmonary Blastoma, and Endometrial Cancer.

Samir Narayan is a Radiation Oncologist practicing medicine in Ypsilanti, Michigan. Dr. Narayan is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Familial Prostate Cancer, and Posterior Fossa Tumor.

Carolyn Carrera is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Carrera is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, and Angiosarcoma.

Bryan Squires is a Radiation Oncologist practicing medicine in Ypsilanti, Michigan. Dr. Squires is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His clinical expertise encompasses HER-2 Positive Breast Cancer, Lung Cancer, Metastatic Brain Tumor, and Prostate Cancer.

Tara Breslin is a Surgical Oncologist practicing medicine in Ypsilanti, Michigan. Dr. Breslin is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Intraductal Papilloma, Mastectomy, and Lymphadenectomy.

Christopher Reynolds is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Reynolds is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), Neuroendocrine Tumor, and Bone Marrow Aspiration.

Dr. Erin Cobain is a medical oncologist specializing in the care of patients with breast cancer and inherited cancer predisposition. She serves at Co-Director of the Breast Cancer Clinical Research Team at the Rogel Cancer Center. Dr. Cobain has been on faculty at the University of Michigan since 2016, when she completed her fellowship training. Dr. Cobain specializes in the care of patients with all types of breast cancer and those individuals who are at high risk of developing breast cancer. Dr. Cobain’s research interests include understanding how genetic and genomic testing can be utilized to personalize breast cancer therapy and use of immunotherapy treatments in breast cancer. Dr. Cobain serves as the Principal Investigator of a National Cancer Institute sponsored clinical trial exploring the role of combination chemotherapy and immunotherapy treatment in patients with hormone receptor positive, HER2 negative early-stage breast cancer with high genomic risk. Dr. Cobain is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast.

Dr. Schott is a Professor of Medicine and is the Associate Director of Clinical Research for the Rogel Cancer Center. She is an expert in the field of breast cancer, has an active breast cancer practice, and frequently gives lectures and publishes about breast cancer treatment. Her research is focused on the development of new treatments for breast cancer, and the testing of these treatments in clinical trials. Dr. Schott is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, HER2 Negative Breast Cancer, and Tissue Biopsy.

Dr. Van Poznak received her medical degree from Cornell University Medical College and internal medicine residency training at The New York Hospital-Cornell Medical Center in New York City. Remaining in New York, she completed her fellowship in medical oncology at Memorial Sloan-Kettering Cancer Center (MSKCC) and started her oncology practice at MSKCC on the Breast Cancer Medicine Service. In 2006, Dr. Van Poznak joined the faculty of the University of Michigan where she is an active clinician in the U-M Rogel Cancer Center Breast Care Center. Her clinical and translational research is in breast cancer and its relationship to bone - including the diagnosis, treatment and prevention of osteoporosis in breast cancer patients, breast cancer biomarkers predicting site specific relapse, and bone metastases. Dr. Van Poznak is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, and Breast Cancer. Dr. Van Poznak is board certified in Medical Oncology.

Dr. Jeffrey Smerage is a hematologist/oncologist specializing in breast cancer. He received both a medical and doctoral degree from the University of Florida and then went on to residency training at the University of Virginia. In 2004, after completing a fellowship in hematology and oncology at the University of Michigan, Dr. Smerage joined the faculty of the Department of Internal Medicine and began his practice in the Breast Care Center. Dr. Smerage is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Smerage is board certified in Medical Oncology and Clinical Informatics.

Dr. Tasha Hughes is a Clinical Associate Professor of Surgery and a surgical oncologist at the University of Michigan. Her clinical efforts are focused on the treatment of breast cancer and melanoma. She is a health services research with a program centered around provider communication, provider bias and health care safety and quality.Dr. Hughes completed her surgical oncology training at Ohio State University Wexner Medical Center and James Comprehensive Cancer Society and her residency at Rush University Medical Center and John H. Stroger Hospital of Cook County in Chicago, IL. Dr. Hughes is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Lymphadenectomy.

Dr. Burness is driven by a desire to improve therapies for breast cancer patients. Her research arises from her clinical experiences in treating breast cancer patients. Her research focus is on the development of therapies to target cancer stem cells, specifically ways to alter DNA repair mechanisms and inflammation in cancer stem cells. This innovative approach to treating breast cancer holds promise for identifying new therapeutic targets and improving therapeutic regimens. Dr. Burness studies these approaches in the laboratory and in clinical trials, with the goal of rapidly translating her laboratory findings into use in the clinic to improve outcomes for breast cancer patients. Dr. Burness is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Breast Cancer in Men, Angiosarcoma, and Paget Disease of the Breast. Dr. Burness is board certified in Internal Medicine and Medical Oncology.

Tucker Jennings is a Surgical Oncologist practicing medicine in Wayne, Michigan. He has been practicing medicine for over 30 years. Dr. Jennings is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Subareolar Abscess, Breast Cancer, Paget Disease of the Breast, and HER-2 Positive Breast Cancer. Dr. Jennings is board certified in American Board Of Surgery. Dr. Jennings is currently accepting new patients.

Poorni Manohar is a Hematologist practicing medicine in Ann Arbor, Michigan. Dr. Manohar is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and HER-2 Positive Breast Cancer.